BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 9371228)

  • 1. Regulation of the steps of angiogenesis by human head and neck squamous cell carcinomas.
    Benefield J; Petruzzelli GJ; Fowler S; Taitz A; Kalkanis J; Young MR
    Invasion Metastasis; 1996; 16(6):291-301. PubMed ID: 9371228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EGFR antisense treatment of human HNSCC cell lines down-regulates VEGF expression and endothelial cell migration.
    Riedel F; Götte K; Li M; Hörmann K; Grandis JR
    Int J Oncol; 2002 Jul; 21(1):11-6. PubMed ID: 12063543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abrogation of VEGF expression in human head and neck squamous cell carcinoma decreases angiogenic activity in vitro and in vivo.
    Riedel F; Götte K; Li M; Hörmann K; Grandis JR
    Int J Oncol; 2003 Sep; 23(3):577-83. PubMed ID: 12888890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular endothelial growth factor in squamous cell head and neck carcinoma: expression and prognostic significance.
    Salven P; Heikkilä P; Anttonen A; Kajanti M; Joensuu H
    Mod Pathol; 1997 Nov; 10(11):1128-33. PubMed ID: 9388064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The platelet-derived growth factor receptor as a target for vascular endothelial growth factor-mediated anti-angiogenetic therapy in head and neck cancer.
    Bran B; Bran G; Hörmann K; Riedel F
    Int J Oncol; 2009 Jan; 34(1):255-61. PubMed ID: 19082496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of tecogalan sodium on angiogenesis in vitro by choroidal endothelial cells.
    Sakamoto T; Ishibashi T; Kimura H; Yoshikawa H; Spee C; Harris MS; Hinton DR; Ryan SJ
    Invest Ophthalmol Vis Sci; 1995 May; 36(6):1076-83. PubMed ID: 7537258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of proinflammatory and proangiogenic cytokines in patients with head and neck cancer.
    Chen Z; Malhotra PS; Thomas GR; Ondrey FG; Duffey DC; Smith CW; Enamorado I; Yeh NT; Kroog GS; Rudy S; McCullagh L; Mousa S; Quezado M; Herscher LL; Van Waes C
    Clin Cancer Res; 1999 Jun; 5(6):1369-79. PubMed ID: 10389921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Signal transducers and activators of transcription 3 up-regulates vascular endothelial growth factor production and tumor angiogenesis in head and neck squamous cell carcinoma.
    Masuda M; Ruan HY; Ito A; Nakashima T; Toh S; Wakasaki T; Yasumatsu R; Kutratomi Y; Komune S; Weinstein IB
    Oral Oncol; 2007 Sep; 43(8):785-90. PubMed ID: 17169602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatocyte growth factor/scatter factor-induced activation of MEK and PI3K signal pathways contributes to expression of proangiogenic cytokines interleukin-8 and vascular endothelial growth factor in head and neck squamous cell carcinoma.
    Dong G; Chen Z; Li ZY; Yeh NT; Bancroft CC; Van Waes C
    Cancer Res; 2001 Aug; 61(15):5911-8. PubMed ID: 11479233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Coexpression of VEGF and bFGF is associated with increased vascular density in head and neck carcinomas].
    Riedel F; Götte K; Schwalb J; Bergler W; Hörmann K
    Laryngorhinootologie; 2000 Dec; 79(12):730-5. PubMed ID: 11199455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular endothelial growth factor is a marker of tumor invasion and metastasis in squamous cell carcinomas of the head and neck.
    Sauter ER; Nesbit M; Watson JC; Klein-Szanto A; Litwin S; Herlyn M
    Clin Cancer Res; 1999 Apr; 5(4):775-82. PubMed ID: 10213212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 expression in squamous cell carcinomas of the head and neck.
    Neuchrist C; Erovic BM; Handisurya A; Fischer MB; Steiner GE; Hollemann D; Gedlicka C; Saaristo A; Burian M
    Head Neck; 2003 Jun; 25(6):464-74. PubMed ID: 12784238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular endothelial growth factor isoforms display distinct activities in promoting tumor angiogenesis at different anatomic sites.
    Guo P; Xu L; Pan S; Brekken RA; Yang ST; Whitaker GB; Nagane M; Thorpe PE; Rosenbaum JS; Su Huang HJ; Cavenee WK; Cheng SY
    Cancer Res; 2001 Dec; 61(23):8569-77. PubMed ID: 11731444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration.
    Wood JM; Bold G; Buchdunger E; Cozens R; Ferrari S; Frei J; Hofmann F; Mestan J; Mett H; O'Reilly T; Persohn E; Rösel J; Schnell C; Stover D; Theuer A; Towbin H; Wenger F; Woods-Cook K; Menrad A; Siemeister G; Schirner M; Thierauch KH; Schneider MR; Drevs J; Martiny-Baron G; Totzke F
    Cancer Res; 2000 Apr; 60(8):2178-89. PubMed ID: 10786682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular endothelial growth factor receptor 2 (VEGFR2) expression in squamous cell carcinomas of the head and neck.
    Neuchrist C; Erovic BM; Handisurya A; Steiner GE; Rockwell P; Gedlicka C; Burian M
    Laryngoscope; 2001 Oct; 111(10):1834-41. PubMed ID: 11801954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of vascular endothelial growth factor receptors on tumor cells in head and neck squamous cell carcinoma.
    Lalla RV; Boisoneau DS; Spiro JD; Kreutzer DL
    Arch Otolaryngol Head Neck Surg; 2003 Aug; 129(8):882-8. PubMed ID: 12925349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual role of VEGF family members in the pathogenesis of head and neck cancer (HNSCC): possible link between angiogenesis and immune tolerance.
    Strauss L; Volland D; Kunkel M; Reichert TE
    Med Sci Monit; 2005 Aug; 11(8):BR280-92. PubMed ID: 16049374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of transforming growth factor beta1 in head and neck epithelia results in inflammation, angiogenesis, and epithelial hyperproliferation.
    Lu SL; Reh D; Li AG; Woods J; Corless CL; Kulesz-Martin M; Wang XJ
    Cancer Res; 2004 Jul; 64(13):4405-10. PubMed ID: 15231647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inverse correlation of apoptotic and angiogenic markers in squamous cell carcinoma of the head and neck.
    Riedel F; Götte K; Bergler W; Hörmann K
    Oncol Rep; 2001; 8(3):471-6. PubMed ID: 11295065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparin-binding growth factor(s) derived from head and neck squamous cell carcinomas induce endothelial cell proliferations.
    Petruzzelli GJ; Benefield J; Taitz AD; Fowler S; Kalkanis J; Scobercea S; West D; Young MR
    Head Neck; 1997 Oct; 19(7):576-82. PubMed ID: 9323145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.